Jackson’s Hobbit: the journey begins

WELLINGTON (Reuters) – Film maker Peter Jackson wants to scare children with his latest movie – and perhaps even a few grown ups.

The first of the Hobbit movie trilogy – “The Hobbit: An Unexpected Journey” – is about to hit theatres, and Jackson says he’s tried to hold true to its roots as a children’s fantasy story, with scary bits.

“If they’re scared of the trolls great, if they’re scared of the goblins great, they know there are no goblins, they know there are no trolls, it’s a safe kind of danger,” he says.

The film, produced by MGM and Time Warner Inc, is the fourth in the Oscar-winning Jackson’s blockbuster “Lord of the Rings” film franchise, based on the books of author J.R.R. Tolkien.

It follows the journey of hobbit Bilbo Baggins, reluctantly pushed into travelling with 13 dwarves to steal treasure from a dragon and regain their homeland. During his travels, he comes by the ring that he later passes onto kinsman Frodo Baggins, which was at the core of the “Rings” trilogy.

Jackson says he’s worked to keep distance between the Hobbit, published in 1937, and the much darker Lord of the Rings, which came out nearly 20 years later.

“The Lord of the Rings has an apocalyptic sort of heavy themic end-of-the world quality to it, which the Hobbit doesn’t, which is one of the delights of it,” he said.

POMPOUS AND SMALL MINDED

The pointy eared, hairy footed hobbit Bilbo is played by British actor Martin Freeman, who says he’s tried to make Bilbo his own creation, a character audiences can root for despite his initial pomposity and small mindedness.

“You have to be able to follow him for the duration of the film, but I wanted him to be open and changeable and ready to be surprised,” Freeman said.

A key scene is an encounter in a cave between Bilbo and the creature Gollum, reprised in full computer generated splendor by Andy Serkis with the distinctive throaty whisper.

“It was a very rich experience,” he said, adding that playing Gollum again was “an absolute thrill”.

Such is the affection for the creature, who calls the magic ring “Precious”, that a 13 meter (42 feet) sculpture of Gollum hangs in the airport terminal at Wellington, which regards itself as the spiritual home of the Tolkien films and terms itself the “Middle of Middle Earth”.

Returning actors from the Rings trilogy, many of whom have only passing mention in the book, were no less enthusiastic. Ian McKellen returns for a leading role as the wispy-haired, grey bearded wizard, Gandalf, while Cate Blanchett is the elven queen Galadriel and Elijah Wood appears as Frodo Baggins.

“You couldn’t not come back, you had to come back,” says Hugo Weaving, the leader of the elves, Elrond.

HOBBIT – A FRAUGHT JOURNEY

The Hobbit film journey has not been without its setbacks.

Metro-Goldwyn-Mayer, owners of the film rights to the Tolkien books, had financial woes, prompting original director Guillermo del Toro to pull out and Jackson, already script writer and executive producer, to step in.

A major labor dispute prompted threats to move production out of New Zealand, and was solved by changing labor laws, while Jackson suffered a perforated ulcer and underwent surgery, delaying the film still further.

Though only two films were planned originally, Jackson has tapped Tolkien’s appendices to the Rings to make it into three.

Audiences are also getting more visual bangs for their buck, with the movies filmed in 3D and at 48 frames per second (fps), double the industry standard.

This delivers clearer pictures, but opinion is divided, with some critics calling it cartoon-like and jarring.

Jackson says he wants to drag the iPad generation back into theatres and the romance, excitement and mystery they offer.

“It’s more realistic, it’s more immersive. I almost feel a responsibility as a film maker to try to do my part at encouraging people to come to the movies, to watch the film in a cinema,” he said.

The second film “The Hobbit: The Desolation of Smaug” will be released in December next year, with the third “The Hobbit: There and Back Again” is due in mid-July 2014.

(Reporting by Gyles Beckford, editing by Elaine Lies)

Movies News Headlines – Yahoo! News

Read More..

One toke over the line in Washington state, where pot is now legal

SEATTLE -- More than 100 hard-core tokers gathered under the Space Needle at the stroke of midnight Wednesday night to light one up in celebration of Washington state’s new marijuana law, which makes it legal for those 21 and older to possess an ounce or less of pot.

Voters in Washington and Colorado approved the nation’s first recreational marijuana laws in November, and though Colorado’s doesn’t take effect until January, the Washington initiative allows pot possession as of Thursday — though it’s still illegal for the moment to buy, sell or grow marijuana.

And smoking publicly remains against the law. That didn't stop the bandanna-clad crew puffing on pipes and joints under a chilly night sky early Thursday, and it appeared  the Seattle Police Department was not in the mood to arrest anyone on a night most seemed to take as celebratory.

"The Dude abides, and says, 'Take it inside!' " the SPD posted on its police blotter, under a photo of Jeff Bridges as "The Big Lebowski."

The department issued a bulletin to officers directing them "until further notice" to take no enforcement action, other than a verbal warning, against those violating the new law, known as Initiative 502.

"We had a city ordinance prior to this that said marijuana enforcement was our lowest enforcement priority," police department spokesman Jeff Kappel told the Los Angeles Times.

The state’s Liquor Control Board, tasked with setting up regulations to carry out the law, will over the next year draft a framework for licensing growers, handlers and retailers that initiative supporters hope will put black market drug dealers out of business.

The state's existing medical marijuana law remains unchanged.

"I think we have some ability to use our experience in regulating liquor, which is to me a similar public safety kind of product," the control board’s administrative director, Pat Kohler, said in an interview. "You want to ensure it doesn’t get in the hands of minors, and you want to make sure it doesn’t get in the wrong hands, where it can be used improperly."

State officials believe the hefty taxation on state-produced marijuana called for under the law could bring in $2 billion over the next five years.

Still unclear is what move may be next from the federal government, which still considers marijuana possession a felony.

The U.S. attorney’s office in Seattle issued a warning from the U.S. Justice Department on Wednesday that said it was taking its enforcement responsibility seriously.

"The department’s responsibility to enforce the Controlled Substances Act remains unchanged," the statement said. "Regardless of any changes in state law, including the change that will go into effect on Dec. 6 in Washington state, growing, selling or possessing any amount of marijuana remains illegal under federal law."

Likewise, it said, bringing pot onto any federal property, including national parks and forests, military installations and courthouses, would continue to be a poor idea.

ALSO:

Outrage over N.Y. Post cover of man in train's path

Man in wheelchair charged in killing at Georgia gas station

James Holmes case: University releases thousands of emails

Read More..

2012 Was the Year of the Drone in Afghanistan

The soldiers and marines are packing their bags. The pilots are sitting on the tarmac. But the armed robotic planes are busier than they’ve ever been: revised U.S. military statistics show a much, much larger drone war in Afghanistan than anyone suspected.

Last month, military stats revealed that the U.S. had launched some 333 drone strikes in Afghanistan thus far in 2012. That made Afghanistan the epicenter of U.S. drone attacks — not Pakistan, not Yemen, not Somalia. But it turns out those stats were off, according to revised ones released by the Air Force on Thursday morning. There have actually been 447 drone strikes in Afghanistan this year. That means drone strikes represent 11.5 percent of the entire air war — up from about 5 percent last year.

Never before in Afghanistan have there been so many drone strikes. For the past three years, the strikes have never topped 300 annually, even during the height of the surge. Never mind 2014, when U.S. troops are supposed to take a diminished role in the war and focus largely on counterterrorism. Afghanistan’s past year, heavy on insurgent-hunting robots, shows that the war’s future has already been on display.

It’s not just that the drone war in Afghanistan is so big. It’s that the broader air war is winding down. As the chart above shows, the Air Force flew fewer intelligence, surveillance and reconnaissance missions in 2012 than it did in 2011, although the number of spy missions in 2012 is still greater than in 2010 or 2009. This year has seen over 1,000 fewer aerial attacks, by manned and remotely piloted aircraft alike, than there were during the surge years of 2010 and 2011. Total sorties are even lower than their 2009 levels. The only exception to the downward slope: drone strikes.

That suggests a pattern that may endure through the next two years of troop reductions. As the humans leave, the robots take up the slack.

The U.S. and Afghanistan have begun negotiations on what a residual troop presence is supposed to look like. So far, it’s believed that the Pentagon wants to leave behind between 5,000 and 10,000 troops, to continue to train the Afghan military, hunt terrorists and generally ensure Afghanistan doesn’t collapse. And before the New Year, Gen. John Allen, the outgoing commander of the war, is supposed to recommend to President Obama how fast next year’s troop drawdowns ought to proceed. Pentagon officials insist nothing’s etched in stone.

But we might not have to wait for 2014 to see the future of the Afghanistan war. “We may well see the development of counterterrorism become more important as time goes on,” Allen told the Senate last year. This year proved Allen wasn’t blowing smoke. U.S. special operations forces underwent a major command overhaul and now operate out of a private base run by the company formerly known as Blackwater. Super-sizing the drone war is fully in line with that broader shift. This may have been the year of the drone in Afghanistan, but the drones aren’t going home any time soon.

Read More..

Latest James Bond movie breaks UK box office record

LONDON (Reuters) – “Skyfall“, the 23rd official James Bond movie, has become the most successful film in British box office history, earning 94.3 million pounds ($ 152 million), its producers said on Wednesday.

The tally, earned over 40 days, surpasses the previous record of 94.0 million pounds set by 2009 3D adventure film “Avatar” over its 11 month run in UK cinemas, although the figures do not take inflation into account.

Skyfall, which has been well received by critics, stars Daniel Craig in his third outing as 007, and is directed by Sam Mendes.

In it Bond and British spymaster M, played by Judi Dench, are pitted against technological wizard Silva (Javier Bardem) who is bent on revenge.

“We are very proud of this film and thank everybody, especially Daniel Craig and Sam Mendes, who have contributed to its success,” said co-producers Michael G. Wilson and Barbara Broccoli in a statement.

Globally, Skyfall has some way to go to match Avatar. It has earned $ 870 million in ticket sales around the world, according to movie tracking site Boxofficemojo.com, compared with Avatar’s record $ 2.8 billion.

According to the same website, Avatar’s adjusted box office total comes in at 14th in cinema history, with the 1939 classic “Gone With the Wind” in pole position.

(Reporting by Mike Collett-White, editing by Paul Casciato)

Movies News Headlines – Yahoo! News

Read More..

Extended Use of Breast Cancer Drug Suggested

The widely prescribed drug tamoxifen already plays a major role in reducing the risk of death from breast cancer. But a new study suggests that women should be taking the drug for twice as long as is now customary, a finding that could upend the standard that has been in place for about 15 years.

In the study, patients who continued taking tamoxifen for 10 years were less likely to have the cancer come back or to die from the disease than women who took the drug for only five years, the current standard of care.

“Certainly, the advice to stop in five years should not stand,” said Prof. Richard Peto, a medical statistician at Oxford University and senior author of the study, which was published in The Lancet on Wednesday and presented at the San Antonio Breast Cancer Symposium.

Breast cancer specialists not involved in the study said the results could have the biggest impact on premenopausal women, who account for a fifth to a quarter of new breast cancer cases. Postmenopausal women tend to take different drugs, but some experts said the results suggest that those drugs might be taken for a longer duration as well.

“We’ve been waiting for this result,” said Dr. Robert W. Carlson, a professor of medicine at Stanford University. “I think it is especially practice-changing in premenopausal women because the results do favor a 10-year regimen.”

Dr. Eric P. Winer, chief of women’s cancers at the Dana-Farber Cancer Institute in Boston, said that even women who completed their five years of tamoxifen months or years ago might consider starting on the drug again.

Tamoxifen blocks the effect of the hormone estrogen, which fuels tumor growth in estrogen receptor-positive cancers that account for about 65 percent of cases in premenopausal women. Some small studies in the 1990s suggested that there was no benefit to using tamoxifen longer than five years, so that has been the standard.

About 227,000 cases of breast cancer are diagnosed each year in the United States, and an estimated 30,000 of them are in premenopausal women with estrogen receptor-positive cancer and prime candidates for tamoxifen. But postmenopausal women also take tamoxifen if they cannot tolerate the alternative drugs, known as aromatase inhibitors.

The new study, known as Atlas, included nearly 7,000 women with ER-positive disease who had completed five years of tamoxifen. They came from about three dozen countries. Half were chosen at random to take the drug another five years, while the others were told to stop.

In the group assigned to take tamoxifen for 10 years, 21.4 percent had a recurrence of breast cancer in the ensuing 10 years, meaning the period 5 to 14 years after their diagnoses. The recurrence rate for those who took only five years of tamoxifen was 25.1 percent.

About 12.2 percent of those in the 10-year treatment group died from breast cancer, compared with 15 percent for those in the control group.

There was virtually no difference in death and recurrence between the two groups during the five years of extra tamoxifen. The difference came in later years, suggesting that tamoxifen has a carry-over effect that lasts long after women stop taking it.

Whether these differences are big enough to cause women to take the drug for twice as long remains to be seen.

“The treatment effect is real, but it’s modest,” said Dr. Paul E. Goss, director of breast cancer research at the Massachusetts General Hospital.

Tamoxifen has side effects, including endometrial cancer, blood clots and hot flashes, which cause many women to stop taking the drug. In the Atlas trial, it appears that roughly 40 percent of the patients assigned to take tamoxifen for the additional five years stopped prematurely.

Some 3.1 percent of those taking the extra five years of tamoxifen got endometrial cancer versus 1.6 percent in the control group. However, only 0.6 percent of those in the longer treatment group died from endometrial cancer or pulmonary blood clots, compared with 0.4 percent in the control group.

“Over all, the benefits of extended tamoxifen seemed to outweigh the risks substantially,” Trevor J. Powles of the Cancer Center London, said in a commentary published by The Lancet.

Dr. Judy E. Garber, director of the Center for Cancer Genetics and Prevention at Dana-Farber, said many women have a love-hate relationship with hormone therapies.

“They don’t feel well on them, but it’s their safety net,” said Dr. Garber, who added that the news would be welcomed by many patients who would like to stay on the drug. “I have patients who agonize about this, people who are coming to the end of their tamoxifen.”

Emily Behrend, who is a few months from finishing her five years on tamoxifen, said she would definitely consider another five years. “If it can keep the cancer away, I’m all for it,” said Ms. Behrend, 39, a single mother in Tomball, Tex. She is taking the antidepressant Effexor to help control the night sweats and hot flashes caused by tamoxifen.

Cost is not considered a huge barrier to taking tamoxifen longer because the drug can be obtained for less than $200 a year.

The results, while answering one question, raise many new ones, including whether even more than 10 years of treatment would be better still.

Perhaps the most important question is what the results mean for postmenopausal women. Even many women who are premenopausal at the time of diagnosis will pass through menopause by the time they finish their first five years of tamoxifen, or will have been pushed into menopause by chemotherapy.

Postmenopausal patients tend to take aromatase inhibitors like anastrozole or letrozole, which are more effective than tamoxifen at preventing breast cancer recurrence, though they do not work for premenopausal women.

Mr. Peto said he thought the results of the Atlas study would “apply to endocrine therapy in general,” meaning that 10 years of an aromatase inhibitor would be better than five years. Other doctors were not so sure.

The Atlas study was paid for by various organizations including the United States Army, the British government and AstraZeneca, which makes the brand-name version of tamoxifen.

Read More..

Dave Brubeck, jazz legend, dies at 91

Dave Brubeck, the jazz pianist, composer and bandleader behind the legendary Dave Brubeck Quartet, has died at age 91.

The death of Brubeck, whose composition “Take Five” became a jazz standard and the bestselling jazz song of all time, was confirmed Wednesday by the Associated Press. Brubeck would have turned 92 Thursday.

According to the AP, Brubeck died of heart failure after being stricken while on the way to a cardiologist's  appointment in Connecticut.

Photos: Dave Brubeck | 1920 - 2012

Brubeck, born Dec. 6, 1920, in Concord, Calif., was the son of a cattle rancher. His mother was a classically trained pianist. Although he studied zoology at the College of the Pacific in Stockton, he came to love the music department. While serving in the Army during World War II, Brubeck formed the band the Wolfpack.  After the war in the Bay Area he experimented with music groups and styles.

In 1951 he and alto saxophonist Paul Desmond created what would become one of the most popular acts of West Coast jazz, the Dave Brubeck Quartet. The quartet's most famous song was "Take Five," from the 1959 release "Time Out.

During his career, Brubeck also created standards such as "The Duke" and "In Your Own Sweet Way."

In a 2010 article on the occasion of Brubeck's 90th birthday, the Los Angeles Times interviewed the jazz legend and noted that although jazz may not occupy the center of the musical universe, even people who know little, if anything, about jazz know of Brubeck:

"Through more than 60 years of recordings and performances at colleges, concert halls, festivals and nightclubs all over the world, Brubeck put forth a body of work — as pianist, composer and bandleader — that is as accessible as it is ingenious, as stress-free as it is rhythmically emphatic, as open-hearted as it is wide-ranging."

Details of Brubeck's death coming soon at the Los Angeles Times.

Read More..

240-Million-Year-Old Fossils Came From First Dinosaur ... Maybe

By Michael Balter, ScienceNOW

A team of paleontologists thinks it may have identified the earliest known dinosaur—a creature no bigger than a Labrador retriever that lived about 243 million years ago. That’s at least 10 million years earlier than the oldest known dinos and could change researchers’ views of how they evolved. But some scientists, including the study’s authors, caution that the fossils could instead represent a close dino relative.

Tracing back the earliest dinosaurs has not been easy. Fossils that old tend to be fragmentary, and researchers don’t always agree about their evolutionary pedigree. Paleontologists do agree, however, that pint-sized specimens found in Argentina and dated to 230 million years ago—with names like Eoraptor and Eodromaeus—are true dinosaurs. And in 2010, a team led by Sterling Nesbitt, a paleontologist at the University of Washington, Seattle, reported in Nature the discovery of a close dinosaur relative in Tanzania’s Manda Beds, a geological formation dated to between about 242 million and 245 million years ago. That specimen, called Asilisaurus, is not a dinosaur, but belongs to a so-called “sister taxon”—that is, the closest it can be to a dinosaur without actually being one.

That made Nesbitt and his colleagues take a closer look at what else has been found in the Manda Beds. One set of fossils, including an arm bone and several vertebrae, had been discovered in the 1930s and studied for decades by Alan Charig, a famed paleontologist at London’s Natural History Museum. Before he died in 1997, Charig named the specimens Nyasasaurus, but he never published his conclusions about whether it was a dinosaur.

For the new study, which also includes Nyasasaurus fossils housed in the South African Museum in Cape Town, Nesbitt’s team carried out a systematic comparison of the bones with those of other dinosaurs and their relatives. The researchers, who report their findings today in Biology Letters, find a number of features characteristic of true dinos. For example, Nyasasaurus has a broad crest of bone along the edge of its upper arm, to which the animal’s chest muscles would have attached; this crest appears to extend more than 30% of the bone’s length, a telltale dino feature. Nyasasaurus also has three vertebrae in its sacrum, the part of the spine that is attached to the pelvis, whereas dino ancestors only had two. And a microscopic study of the arm bone, carried out by team member Sarah Werning of the University of California, Berkeley, shows that it had grown very rapidly during the animal’s development, also typical of dinosaurs as well as later mammals and birds.

Nesbitt says that this combination of characteristics, rather than any one taken alone, makes a strong case that Nyasasaurus was “either a dinosaur or the closest relative.” Moreover, by the time early dinosaurs such as Eoraptor and Eodromaeus show up in Argentina at least 10 million years later, they already represent diverse groups that must have been evolving for millions of years. That means that dinosaur evolution must have begun a considerable time before that, Nesbitt says. And it makes Nyasasaurus a good candidate for an early dino, especially as a very close dinosaur relative, Asilisaurus, was also living in the Manda Beds some 243 million years ago.

This story provided by ScienceNOW, the daily online news service of the journal Science.

Read More..

“The Message” deemed greatest hip hop song ever

LOS ANGELES (Reuters) – The 1982 hit “The Message” by Grandmaster Flash and the Furious Five was named the greatest hip hop song of all time on Wednesday, in the first such list by Rolling Stone magazine to celebrate the young but influential music genre.

“The Message,” which tops a list of 50 influential hip hop songs, was the first track “to tell, with hip hop‘s rhythmic and vocal force, the truth about modern inner-city life in America,” Rolling Stone said.

Grandmaster Flash and the Furious Five, a hip hop collective from the south Bronx in New York, was formed in 1978 and became one of the pioneers of the hip hop genre.

The full list spanned songs ranging from Sugarhill Gang’s 1979 hit “Rapper’s Delight,” which came in at No. 2, to Kanye West‘s 2004 hit “Jesus Walks,” which landed at No. 32.

“It’s a list that would have been a lot harder to do ten or 15 years ago because hip hop is so young,” Nathan Brackett, deputy managing editor of Rolling Stone, told Reuters.

“We’ve reached the point now where hip hop acts are getting into the (Rock and Roll) Hall Of Fame… it just felt like the right time to give this the real Rolling Stone treatment.”

Rolling Stone‘s top 10 featured mostly hip hop veterans, such as Run-D.M.C.’s 1983 track “Sucker M.C.’s,” Dr. Dre and Snoop Dogg’s 1992 hit “Nuthin’ But A ‘G’ Thang,” Public Enemy’s 1990 song “Fight The Power” and Notorious B.I.G’s 1994 hit “Juicy.”

Other influential artists in the top 50 songs included Beastie Boys, who came in at No. 19 with “Paul Revere,” and recordings by Jay-Z, Eminem, Missy Elliot, Outkast, Lauryn Hill, LL Cool J, Nas and the late rapper 2Pac.

The list of 50 songs was compiled by a 33-panel of members comprising Rolling Stone editors and hip hop experts. They included musician Ahmir “Questlove” Thompson of The Roots, who Brackett described as “an incredible encyclopedia” of both old and new hip hop knowledge.

Brackett noted that some songs considered to be one-hit wonders, such as Audio Two’s 1988 hit “Top Billin’,” made the final selection.

“The references in those songs become the building blocks of all these other songs down the road … they become touchstones, really part of the meat of hip hop songs going forward,” Brackett said.

The full list will be released online at RollingStone.com and in the pop culture magazine on newsstands on December7. The issue will feature four different covers of Eminem, Jay-Z, Notorious B.I.G. and 2Pac.

(Reporting By Piya Sinha-Roy, editing by Jill Serjeant)

Music News Headlines – Yahoo! News

Read More..

Well: New Meaning and Drive in Life After Cancer

When people hear the words “You have cancer,” life is suddenly divided into distinct parts. There was their life before cancer, and then there is life after cancer.

The number of people in that second category continues to grow. In June, the National Cancer Institute reported that an estimated 13.7 million living Americans are cancer survivors, and the number will increase to almost 18 million over the next decade. More than half are younger than 70.

A new book, “Picture Your Life After Cancer,” (American Cancer Society) focuses on the living that goes on after a cancer diagnosis. It’s based on a multimedia project by The New York Times that asked readers to submit photos and their personal stories. So far, nearly 1,500 people have shared their experiences — the good, the bad, the challenging and the inspirational — creating a dramatic photo essay of the varied lives people live in the years after diagnosis.

For Susan Schwalb, a 68-year-old artist from Manhattan, a diagnosis of early-stage breast cancer at the age of 62 led to a lumpectomy, followed by a mastectomy and then failed reconstruction surgery. She discovered that cancer was not only a physical challenge but a mental one as well, and she turned to friends and support groups to cope with the emotional strain. When she saw the “Picture Your Life” project, she submitted a photo of herself wearing a paint-splattered artist’s apron.

“What cancer made me do in my own professional life is to pedal faster,” Ms. Schwalb said in an interview. “I’ve encountered some people who decide to enjoy life, retire, work in a garden. I decided I had to have more of what I wanted in life, and I better move fast because maybe I don’t have the long life I imagined I would have.”

Indeed, a common theme of the “Picture Your Life” project is that cancer spurs people to take long-delayed trips, seek out adventure and spend time with their families. Photos of mountain climbs, a ride on a camel, scuba diving excursions and bicycle trips are now part of the online collage.

Dr. David Posner, associate program director of pulmonary medicine at Lenox Hill Hospital in Manhattan, says a diagnosis of metastatic colon cancer at the age of 47 has helped him relate to his own patients with cancer. The past decade has included nine operations, six recurrences and three rounds of chemotherapy, but Dr. Posner said he never missed more than three weeks of work.

“My salvation has been my family and my work,” he said. “When I was at work I wasn’t thinking about myself, and it was very therapeutic. I see my share of cancer patients, and I motivate them and they motivate me.”

Dr. Posner said he decided to be part of “Picture Your Life” because he wants to get the word out that a cancer diagnosis — even a dire one like his — doesn’t have to define your life.

“I think about someone asking me, ‘So how was your last decade — was it wasted or was it a life filled with a lot of happiness and joy?’ ” he said. “The cancer thing was a pain, but for the most part I’ve had a pretty good time.”

The “Picture Your Life” collage includes photo after photo of survivors with their pets. Sandra Elliott, 59, of Claremont, Calif., submitted a picture of herself with her two golden retrievers, Buddy and Molly. They were just puppies when she received a diagnosis of Stage 2 breast cancer in 2003. During her recovery from surgery and chemotherapy treatments, she took the dogs to romp on the Pomona College campus, near her home, and one day a professional photographer snapped the picture.

“No matter how bad I felt that day, no matter how many chemo treatments or doctors appointments, those two little puppies with these big black eyes would look at me with their tails wagging as if to say, ‘It’s time. It’s time. It’s time to go out!’  ” Ms. Elliott recalled.

“I felt so physically horrible, and I’d look at them and the pure joy on their faces and in their bodies for just being out in nature and being able to smell the air, smell the trees, chase a squirrel — that sheer in-the-moment love of life they showed me really lifted my spirit on a daily basis.”

Ms. Elliott still lives with chronic pain as a result of nerve damage from her cancer treatment, and she can relate to others in the “Picture Your Life” project who worry that their cancer will recur or that they’ll never feel completely normal again. But she says a stronger theme runs through all the pictures and stories.

“We have all been forced to find the joy in the smallest things,” she said. “I’m sitting here looking at a geranium about to bloom. These things are out there — we just have to be reminded to look at them. And cancer is a big reminder.”

Read More..

Starbucks to Open Another 1,500 Cafes in the U.S.

NEW YORK (AP) — Another Starbucks may soon pop up around the corner, with the world's biggest coffee company planning to add at least 1,500 cafes in the U.S. over the next five years.

The plan, which would boost the number of Starbucks cafes in the country by about 13 percent, was announced at the company's investor day in New York Wednesday. Taking into account Canada and South America, the company plans to add a total of 3,000 new cafes in its broader Americas region.

Worldwide, the company says it will have more than 20,000 cafes by 2014, up from its current count of about 18,000. Much of that growth will come from China, which the company says will surpass Canada as its second-biggest market.

Although Starbucks has been intensifying its growth overseas and building its packaged-goods business back at home, the majority of its revenue still comes from its more than 11,100 cafes in the United States.

In an interview ahead of its investor day, CEO Howard Schultz said the U.S. expansion plans are based "on the current strength of our business"

Just a few months ago, the company had predicted it would open just 1,000 new cafes in the country over the next five years.

The upbeat expansion plans mark a turnaround from Starbucks' struggles during the recession. After hitting a rough patch, the company brought back Schultz as CEO in 2008 and embarked on massive restructuring effort that included closing 10 percent of its U.S. stores.

Cliff Burrows, who heads Starbucks' domestic business, said the problem wasn't that Starbucks was oversaturated, but that the company hadn't been careful about its store openings. In the years leading up to the downturn, the company was opening well over 1,000 stores a year. That led to cafes in locations where signs or traffic might not be optimal, he said.

Burrows said Starbucks has gotten more sophisticated, and noted that the cafes opened in recent years are among the company's best performers.

Sales at new cafes are averaging about $1 million a year, for example, above the company's target of $900,000. It costs about $450,000 to build a new cafe.

Since Starbucks already has a broad footprint, the company's expansion is intended to "deepen" its presence with additional stores in markets across the country, said Troy Alstead, Starbucks' chief financial officer. That means establishing stores — including drive-thrus and smaller cafes — in more convenient locations for customers. And even as it expands, Starbucks said it expects to maintain growth at cafes open at least a year. The figure, a key metric of health, has ranged between 7 percent and 8 percent globally in the past three years.

The continued U.S. sales growth will be fueled by the new products, such as Evolution premium juices and Via single-serve coffee packets. Looking forward, Starbucks is also looking to improve its food menu and is testing a new menu of baked goods from La Boulange, a small San Francisco-based chain it acquired earlier this year. The new croissants, loaf cakes and other items will spread to about 2,500 cafes next year and go national sometime in 2014, Burrows said. The company says only about a third of customers currently buy food with their drinks.

In a test aimed at building sales in the evening hours, the company also started serving beer and wine at about a dozen locations earlier this year, with food such as chicken skewers and dates wrapped in bacon.

And most recently, Starbucks announced plans to acquire Teavana, a chain that has 300 locations in shopping malls. When the announcement was made last month, Schultz said the company would "do for tea what it did for coffee."

That includes plans to expand Teavana's presence beyond the shopping mall with stand-alone shops that have "tea bars" that serve specialty drinks. The company declined to say when Starbucks cafes would begin serving Teavana drinks — and it hasn't decided on whether it will continue to sell Tazo in cafes.

After a string of acquisitions in recent years to build on its core business, Schultz indicated Wednesday that the company would hold off on any additional purchases in the near future, noting that the company has "enough to handle."

To build its packaged-goods business, Starbucks plans to let customers earn points on their My Starbucks loyalty card starting next year when they purchase Starbucks bagged coffees in supermarkets and other outlets. Customers currently earn points only when they make purchases in Starbucks stores.

The picture isn't rosy around the globe, however. Europe remains a sore spot for Starbucks, with a key sales figure falling in the region 1 percent during the latest quarter. In an effort to boost results, the company has been closing underperforming stores and licensing of some of its cafes in the region.

In the United Kingdom, Starbucks is also embroiled in a row over its taxes. The company has been doing business in Britain for 15 years and has 700 outlets but it has yet to record a profit — and therefore pay any taxes.

Starbucks says this is due to a complex process where its taxable profits in the U.K. are calculated after royalties paid to its European headquarters in the Netherlands have been deducted.

Following criticism in the U.K. parliament and a campaign by protest group U.K. Uncut, Starbucks said this week that it was reviewing its tax approach.

___

AP reporters Jill Lawless and David Stringer contributed to this report from London

___

Read More..